Vaccine
stringclasses 11
values | Dose
stringclasses 9
values | Geography Type
stringclasses 2
values | Geography
stringclasses 79
values | Birth Year/Birth Cohort
stringclasses 21
values | Dimension Type
stringclasses 6
values | Dimension
stringclasses 26
values | Estimate (%)
float64 4.7
100
⌀ | 95% CI (%)
stringlengths 10
13
⌀ | Sample Size
int64 9
63.4k
⌀ |
|---|---|---|---|---|---|---|---|---|---|
DTaP
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
>400% FPL
| 97.8
|
96.0 to 99.6
| 394
|
≥1 Dose Varicella
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Overall
|
Overall
| 92.5
|
90.2 to 94.7
| 888
|
Rotavirus
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Overall
|
Overall
| 84.7
|
81.7 to 87.7
| 888
|
Hep A
|
≥2 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Overall
|
Overall
| 83.2
|
79.2 to 87.2
| 888
|
Hep B
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
<133% FPL
| 88.8
|
82.4 to 95.2
| 159
|
Hep B
|
≥1 Dose, 3 Day (Birth Dose)
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Overall
|
Overall
| 79.8
|
76.6 to 83.1
| 888
|
Influenza
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Overall
|
Overall
| 71.9
|
68.2 to 75.7
| 888
|
PCV
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
<133% FPL
| 86.2
|
78.9 to 93.5
| 159
|
PCV
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
133% to <400% FPL
| 94.8
|
91.9 to 97.6
| 335
|
Hep A
|
≥2 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
133% to <400% FPL
| 83.4
|
77.1 to 89.6
| 335
|
Hep A
|
≥1 Dose
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Overall
|
Overall
| 89.8
|
87.4 to 92.3
| 888
|
Hep A
|
≥2 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
>400% FPL
| 89.7
|
84.5 to 95.0
| 394
|
Hep A
|
≥1 Dose
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
<133% FPL
| 83.8
|
77.0 to 90.7
| 159
|
PCV
|
≥4 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Overall
|
Overall
| 88
|
85.3 to 90.8
| 888
|
Hep A
|
≥1 Dose
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
133% to <400% FPL
| 88.3
|
84.2 to 92.5
| 335
|
≥1 Dose MMR
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Overall
|
Overall
| 94.3
|
92.5 to 96.2
| 888
|
DTaP
|
≥4 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
<133% FPL
| 75
|
66.5 to 83.5
| 159
|
PCV
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Overall
|
Overall
| 93.6
|
91.5 to 95.8
| 888
|
Rotavirus
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
>400% FPL
| 91.8
|
88.4 to 95.3
| 394
|
Polio
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Overall
|
Overall
| 94.7
|
92.7 to 96.7
| 888
|
DTaP
|
≥4 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Overall
|
Overall
| 86.2
|
83.4 to 89.1
| 888
|
Influenza
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Race and Ethnicity
|
Hispanic
| 74.7
|
63.5 to 85.9
| 67
|
≥1 Dose MMR
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Insurance Coverage
|
Any Medicaid
| 93.4
|
89.9 to 96.9
| 275
|
≥1 Dose MMR
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Insurance Coverage
|
Private Insurance Only
| 96.2
|
94.3 to 98.1
| 563
|
DTaP
|
≥4 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Race and Ethnicity
|
Other or Multiple Races, Non-Hispanic
| 93.5
|
87.3 to 99.7
| 72
|
DTaP
|
≥4 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Race and Ethnicity
|
Hispanic
| 85.3
|
75.5 to 95.1
| 67
|
≥1 Dose Varicella
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Insurance Coverage
|
Private Insurance Only
| 94
|
91.4 to 96.6
| 563
|
≥1 Dose Varicella
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Race and Ethnicity
|
Other or Multiple Races, Non-Hispanic
| 97.6
|
94.3 to 100.0
| 72
|
Hep A
|
≥2 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Insurance Coverage
|
Any Medicaid
| 77.2
|
69.2 to 85.3
| 275
|
Hep A
|
≥2 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Insurance Coverage
|
Private Insurance Only
| 88.6
|
84.3 to 92.8
| 563
|
Polio
|
≥1 Dose
|
States/Local Areas
|
New Hampshire
|
2020
|
Age
|
3 Months
| 92.7
|
86.2 to 96.2
| 189
|
Hib
|
≥1 Dose
|
States/Local Areas
|
New Hampshire
|
2020
|
Age
|
3 Months
| 93.3
|
87.1 to 96.7
| 189
|
Hep B
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2020
|
Age
|
7 Months
| 75.6
|
67.4 to 82.2
| 189
|
Hep B
|
≥1 Dose
|
States/Local Areas
|
New Hampshire
|
2020
|
Age
|
3 Months
| 95.5
|
91.2 to 97.7
| 189
|
Hep B
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2020
|
Age
|
24 Months
| 96.3
|
92.7 to 98.4
| 189
|
PCV
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2020
|
Age
|
7 Months
| 75.1
|
66.2 to 82.2
| 189
|
DTaP
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2020
|
Age
|
13 Months
| 96.7
|
93.1 to 98.5
| 189
|
Rotavirus
| null |
States/Local Areas
|
New Hampshire
|
2019-2020
|
Age
|
8 Months
| 80.9
|
75.5 to 85.3
| 403
|
Hep B
|
≥1 Dose, 1 Day
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
0-1 Days
| 77.2
|
67.4 to 84.8
| 126
|
Hib
|
≥2 Doses
|
States/Local Areas
|
New Hampshire
|
2020-2021
|
Age
|
13 Months
| 95.6
|
92.2 to 97.6
| 315
|
Combined 7 Series
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Race and Ethnicity
|
Other or Multiple Races, Non-Hispanic
| 80.4
|
68.6 to 92.1
| 72
|
Hep B
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Race and Ethnicity
|
White, Non-Hispanic
| 95.2
|
93.3 to 97.2
| 728
|
≥1 Dose MMR
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Principal City
| 88.4
|
81.7 to 95.2
| 165
|
PCV
|
≥4 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Principal City
| 79.7
|
71.5 to 87.9
| 165
|
Hep B
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Non-Principal City
| 95.5
|
92.8 to 98.2
| 384
|
Hep A
|
≥2 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Non-Principal City
| 87.4
|
82.0 to 92.7
| 384
|
Hep B
|
≥1 Dose, 2 Day
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
0-2 Days
| 79.6
|
69.9 to 86.8
| 126
|
Hib
|
≥3 Doses
|
States/Local Areas
|
New Jersey
|
2011
|
Age
|
19 Months
| 94.7
|
91.3 to 96.9
| 264
|
Hib
|
≥3 Doses
|
States/Local Areas
|
New Jersey
|
2012
|
Age
|
19 Months
| 92
|
88.9 to 94.3
| 288
|
Hib
|
≥3 Doses
|
States/Local Areas
|
New Jersey
|
2019
|
Age
|
13 Months
| 87.2
|
79.7 to 92.2
| 279
|
Hep A
|
≥2 Doses
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
35 Months
| 81.7
|
65.5 to 93.4
| 126
|
PCV
|
≥4 Doses
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
19 Months
| 85.4
|
76.0 to 91.5
| 126
|
Hep B
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
24 Months
| 94.7
|
90.3 to 97.6
| 126
|
Hep B
|
≥2 Doses
|
States/Local Areas
|
New Hampshire
|
2020-2021
|
Age
|
13 Months
| 95.1
|
91.7 to 97.1
| 315
|
DTaP
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2020-2021
|
Age
|
19 Months
| 96.9
|
94.3 to 98.3
| 315
|
≥1 Dose Varicella
| null |
States/Local Areas
|
New Hampshire
|
2020-2021
|
Age
|
35 Months
| 94.5
|
89.9 to 97.5
| 315
|
Hib
|
Primary Series
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
7 Months
| 76.8
|
66.7 to 84.6
| 126
|
Hep A
|
≥1 Dose
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
35 Months
| 95.2
|
88.0 to 98.7
| 126
|
DTaP
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
13 Months
| 91.3
|
83.0 to 95.7
| 126
|
Polio
|
≥2 Doses
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
13 Months
| 94.2
|
88.2 to 97.3
| 126
|
Hep B
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2020-2021
|
Age
|
35 Months
| 95.5
|
92.5 to 97.5
| 315
|
Hep A
|
≥1 Dose
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
19 Months
| 91.8
|
84.3 to 95.9
| 126
|
DTaP
|
≥1 Dose
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
3 Months
| 93.7
|
88.3 to 96.7
| 126
|
Hep A
|
≥2 Doses
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
19 Months
| 31.7
|
23.2 to 41.7
| 126
|
PCV
|
≥4 Doses
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
35 Months
| 86.2
|
77.8 to 92.6
| 126
|
DTaP
|
≥4 Doses
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
24 Months
| 89.1
|
80.1 to 95.2
| 126
|
Polio
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
24 Months
| 94.2
|
88.9 to 97.5
| 126
|
Polio
|
≥1 Dose
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
3 Months
| 91.6
|
85.0 to 95.4
| 126
|
≥1 Dose MMR
| null |
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
24 Months
| 96.6
|
93.2 to 98.6
| 126
|
Hib
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
24 Months
| 89.9
|
81.6 to 95.5
| 126
|
Hib
|
Primary Series
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
24 Months
| 92
|
84.8 to 96.6
| 126
|
Hib
|
≥1 Dose
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
3 Months
| 91.5
|
84.9 to 95.3
| 126
|
DTaP
|
≥4 Doses
|
States/Local Areas
|
New Hampshire
|
2020-2021
|
Age
|
35 Months
| 94.6
|
91.2 to 97.1
| 315
|
DTaP
|
≥4 Doses
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
19 Months
| 78.7
|
68.5 to 86.3
| 126
|
Hib
|
Full Series
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
24 Months
| 82.4
|
73.0 to 90.0
| 126
|
PCV
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
19 Months
| 91.5
|
83.4 to 95.9
| 126
|
Hep B
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
7 Months
| 78.6
|
68.8 to 86.0
| 126
|
≥1 Dose Varicella
| null |
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
24 Months
| 93.3
|
86.9 to 97.3
| 126
|
PCV
|
≥4 Doses
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
24 Months
| 86.2
|
77.8 to 92.6
| 126
|
PCV
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
24 Months
| 92.3
|
85.2 to 96.8
| 126
|
PCV
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2020-2021
|
Age
|
35 Months
| 96.4
|
93.1 to 98.4
| 315
|
Hib
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2020-2021
|
Age
|
13 Months
| 90.9
|
85.7 to 94.3
| 315
|
Hep A
|
≥1 Dose
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
24 Months
| 92.3
|
85.7 to 96.6
| 126
|
Hep A
|
≥2 Doses
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
24 Months
| 46.7
|
36.7 to 58.0
| 126
|
DTaP
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
19 Months
| 95
|
90.2 to 97.5
| 126
|
Hep B
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2020-2021
|
Age
|
24 Months
| 95.5
|
92.5 to 97.5
| 315
|
PCV
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
7 Months
| 70
|
59.6 to 78.7
| 126
|
Combined 7 Series
| null |
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
24 Months
| 77.2
|
67.6 to 85.6
| 126
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.